Skip to content

The effectiveness of psychological interventions in patients with breast cancer.

Comparison of the Effectiveness of Meaning-based Therapy, Mindfulness-based Cognitive Therapy, and Emotion-based Therapy on the Quality of Life, Sense of Agency, Perception of Illness, Attitude Towards Death, Distress Tolerance, and Hope in Breast Cancer Patients With Death Anxiety

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20240408061449N1
Enrollment
72
Registered
2024-09-23
Start date
2022-05-22
Completion date
Unknown
Last updated
2025-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast cancer. Malignant neoplasm of nipple and areola

Interventions

Intervention 1: Intervention group one: The first group underwent meaning-based therapeutic intervention for two month(one 90-minute session per week). This intervention was based on Breitbart and Pop

Sponsors

Islamic Azad University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: Breast cancer diagnosis by oncology specialist. Patients are in the second stage of the disease. Patients have received common treatments (such as chemotherapy, radiation therapy, and surgery) within the past year. The age range of patients is between 18 and 50 years old. Patients have the physical ability to participate in sessions. Severe psychological damage such as severe depression is not present based on patients' medical history. Informed consent of patients and their willingness to participate in the research process Ability to answer questions at the level of understanding texts and form questions (at least high school education). No receipt of any psychological treatment for control and experimental groups. Volunteers in the pre-test have a significant level of death anxiety index (scoring higher than 7 on the death anxiety questionnaire). Awareness of their illness and having a full level of consciousness and awareness of time and place.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Quality of life in Aronson questionnaire. Timepoint: 2 month. Method of measurement: Aaronson's specific questionnaire for measuring quality of life in cancer patients.;Death anxiety score in Templer questionnaire. Timepoint: 2 month. Method of measurement: Templer Death Anxiety Questionnaire.;Sense of agency score in Woody, Barnier and Palito questionnaire. Timepoint: 2 month. Method of measurement: The sense of agency questionnaire of Woody, Barnier and Palito.;Illness perception score in Broadbent questionnaire. Timepoint: 2 month. Method of measurement: Brief Illness perception questionnaire of Broadbent.;Distress tolerance score in Simmons and Gaher questionnaire. Timepoint: 2 month. Method of measurement: Simmons and Gaher Distress Tolerance Questionnaire.;Death attitude score in the questionnaire of Wong et al. Timepoint: 2 month. Method of measurement: The death attitude questionnaire of Wong et al.;Hope score in Schneider questionnaire. Timepoint: 2 month. Method of measurement: Schneider hope questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactGholamreza Talebi

Islamic Azad University

rezatalebi@smd.iaun.ac.ir+98 31 3653 2817

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026